- Home
- BLNK vs GNTA Comparison
BLNK vs GNTA Comparison
Compare BLNK & GNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BLNK
- GNTA
- Stock Information
- Founded
- BLNK 2009
- GNTA 2014
- Country
- BLNK United States
- GNTA Italy
- Employees
- BLNK N/A
- GNTA N/A
- Industry
- BLNK Industrial Specialties
- GNTA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- BLNK Consumer Discretionary
- GNTA Health Care
- Exchange
- BLNK Nasdaq
- GNTA Nasdaq
- Market Cap
- BLNK 77.3M
- GNTA 81.2M
- IPO Year
- BLNK N/A
- GNTA 2021
- Fundamental
- Price
- BLNK $0.93
- GNTA $3.06
- Analyst Decision
- BLNK Buy
- GNTA Strong Buy
- Analyst Count
- BLNK 8
- GNTA 1
- Target Price
- BLNK $2.61
- GNTA $25.00
- AVG Volume (30 Days)
- BLNK 2.9M
- GNTA 8.5K
- Earning Date
- BLNK 08-06-2025
- GNTA 01-01-0001
- Dividend Yield
- BLNK N/A
- GNTA N/A
- EPS Growth
- BLNK N/A
- GNTA N/A
- EPS
- BLNK N/A
- GNTA N/A
- Revenue
- BLNK $109,383,000.00
- GNTA N/A
- Revenue This Year
- BLNK N/A
- GNTA N/A
- Revenue Next Year
- BLNK $31.15
- GNTA N/A
- P/E Ratio
- BLNK N/A
- GNTA N/A
- Revenue Growth
- BLNK N/A
- GNTA N/A
- 52 Week Low
- BLNK $0.63
- GNTA $2.79
- 52 Week High
- BLNK $3.75
- GNTA $7.28
- Technical
- Relative Strength Index (RSI)
- BLNK 59.46
- GNTA 22.52
- Support Level
- BLNK $0.84
- GNTA $3.70
- Resistance Level
- BLNK $0.92
- GNTA $6.12
- Average True Range (ATR)
- BLNK 0.07
- GNTA 0.34
- MACD
- BLNK 0.01
- GNTA -0.14
- Stochastic Oscillator
- BLNK 60.25
- GNTA 0.33
About BLNK Blink Charging Co.
Blink Charging Co is an owner, operator, and provider of electric vehicle (EV) charging services. The company offers both residential and commercial EV charging equipment, enabling EV drivers to easily recharge at various location types. The company's business is the sale and distribution of electric vehicle charging equipment and its associated revenues earned from customers and/or Property Partners who use equipment connected to its network. It earns a majority of revenue from U.S.A.
About GNTA Genenta Science S.p.A.
Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon - a product to treat glioblastoma multiforme, a solid tumor affecting the brain.